In melanoma — a tumor type known to derive durable clinical benefit from ICB (72, 90–92) — the IED-related gene set was also expressed by a cluster of cells with fibroblast features, in addition to CD8+, CD4+, and NK cells. This evidence concerns the gene CD8A and melanoma.